US Pharma MarketingThe post Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation appeared first on Medical Device Network.
Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation
Zepto Life’s FungiFlex mould panel is designed to identify 14 clinically important mould species based on cell free fungal DNA detected in plasma. Zepto Life’s FungiFlex mould panel is designed to identify 14 clinically important mould species based on cell free fungal DNA detected in plasma. In the US, the overall population-based prevalence of mould infections run at approximately 15 to 18 cases per 100,000 people, according to data from the US Centers for Disease Control and Prevention (CDC). Credit: Poetra.RH / Shutterstock.com Zepto Life Technology’s invasive mould detection test has secured a breakthrough device designation from the US Food…
Zepto Life’s FungiFlex mould panel is designed to identify 14 clinically important mould species based on cell free fungal DNA detected in plasma.
Source: Medical Device Network